Enjosim
Shanghai
About Enjosim
Enjosim specializes in the R&D, manufacturing, and sales of self-delivery systems, particularly those for biomacromolecule pharmaceuticals. It currently sells a variety of high-precision pen injectors designed for biologics such as insulin, growth hormone, and GLP-1.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2025)
- Website: enjosim.com
- Phone: [email protected]
Industries & Categories
Biopharma, Medical, Medical Device
Canonical: https://fsome.com/organization/enjosim-2243177 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.